Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Emerging toxicities of new anticancer therapies 

Introduction and scientific background

Date

12 Sep 2022

Session

Emerging toxicities of new anticancer therapies 

Topics

Supportive Care and Symptom Management;  Clinical Research;  Multi-Disciplinary and Multi-Professional Cancer Care;  Targeted Therapy;  Cell-Based Therapy;  Immunotherapy

Tumour Site

Presenters

Erica Mayer

Authors

E. Mayer

Author affiliations

  • Dana Farber Cancer Institute, 02115 - Boston/US

Resources

This content is available to ESMO members and event participants.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.